33 -3 (41) 2022 — Nurilloyeva Sh.N. — DISTRIBUTION OF OBESITY IN DIFFERENT CATEGORIES OF HYPERGLYCEMIA

DISTRIBUTION OF OBESITY IN DIFFERENT CATEGORIES OF HYPERGLYCEMIA

Nurilloyeva Sh.N. Bukhara state medical institute

Resume

To study the prevalence of obesity and overweight in different categories of hyperglycemia. Research methods: population, clinical, instrumental, biochemical, statistical. Results obtained and their novelty: In the scientific study, new data were obtained on the prevalence of cases of disorders of the sympathoadrenal phase of the glycemic curve. All categories of hyperglycemia, including sympathoadrenal phase disorders, have been found to be associated with major components of obesity. The original prevalence rates in obese and overweight patients identified in the study may be the basis for the development and implementation of treatment and prevention programs for this syndrome. The use of glycemic coefficients is important in determining the risk of developing obesity and overweight in individuals with normal glycemic levels. Today, obesity is considered not only as the most important risk factor for cardiovascular diseases and type 2 diabetes (according to the World Health Organization, overweight and obesity predetermine the development of up to 44–57% of all cases of type 2 diabetes, 17– 23% of cases of coronary heart disease, 17% of arterial hypertension, 30% of cholelithiasis, 14% of osteoarthritis, 11% of malignant neoplasms, but also reproductive dysfunction and an increased risk of developing cancer.With obesity of the 1st degree, the risk of developing diabetes increases by 2-3 times, of the 2nd degree – by 5 times, and of the 3rd degree – by 10 times

Keywords: Overweight, obesity, diabetes, hyperglycemia,, hyperlipidemia, metabolic syndrome (MS), moxonidine.

First page

169

Last page

173

For citation: Nurilloyeva Sh.N. DISTRIBUTION OF OBESITY IN DIFFERENT CATEGORIES OF HYPERGLYCEMIA //New Day in Medicine 3(41)2022 169-173 https://clck.ru/f4jYA

LIST OF REFERENCES:

1. Bessesen D.G. Overweight and obesity / D.G. Bessesen, R. Kushner. – /M.: Binom. 2004. – 159 p.
2. Ginzburg M.M. Obesity. Influence on the development of metabolic syndrome. Prevention and treatment / M.M. Ginzburg, N.N. Koryukov. M.: Medpraktika, 2002. – S. 23-25. 3. Perova N.V. Pathogenetic bases of the metabolic syndrome as a state of high risk of atherosclerotic diseases / N.V. Perova, V.A. Metelskaya, R.G. Oganov // International medical journal. – 2001. – No. 7(3). – P.6-10.
3. Zimin Yu.V. Metabolic disorders within the framework of metabolic syndrome X (insulin resistance syndrome): the need for strict application of the criteria for diagnosing the syndrome. // Cardiology. -2003. No. 8. – S. 37-41.
4. Haffner S.M. Impaired glucose tolerance, insulin resistance and cardiovascular disease // Diadet Med. – 1997. – Vol. 14 (Suppl. 13). – P. 12-18. 6. Linne Y. / Effects of obesity on women’s reproduction and complications during pregnancy // ObesRew. – 2004. -Vol. 5, No. 3 – P. 137-143.
5. Nurilloyeva Sh.N. Assesment of the methods of the state of hyperglycemia at different body masses Academicia an international multidisciplinary research journal ISSN: 2249-7137.Vol 11, Issue 9, September 2021, Impact Factor: SJIF 2021 = 7.492, page no 359-366.
6. Badritdinova M.N., Nurilloyeva Sh.N. Difficulties and prospects for non-drug treatment of metabolic syndrome. Art of medicine. International medical scientific journal 10.5281/zenod o.5658996.Vol 1, Issue 3, May 2021 no 51-59.
7. Nurilloyeva Sh.N., Juraeva X.I. Adequacy pharmacotherapy of metabolic syndrome. World journal of pharmaceutical research ISSN: 2277-7103.Vol 9, Issue12, September 2020 Impact Factor: SJIF 2020 = 8.084, page no 48-53.
8. Badritdinova M.N., Nurilloyeva Sh.N. Body weight  an obesity prevention in different categories of  hyperglycemia. Тиббиётда янги кун. 2(34/3) 2021, 33-39 бетлар
9. Badritdinova M.N., Nurilloyeva Sh.N. Dependence of glycemic curvature in different phases of obesity. //New day in medicine,  №3(35)2021, 256-259 бетлар